Owners, management and financials
CVR: 28293364
DKK 4,044,322
Gross profit
Net result: DKK -4,810,707
Nobel Biocare AB (100%)
CVR · view owners
Jan Jerne
Board: Magnus Karl Andreas Pettersson (chair) and 2 members
CVR · view management
Active
Founded 24 November 2004
CVR · view overview
3 employees
CVR · 2018
Director registered: Jan Jerne
CVR · 15/08/2025
View the full event history
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.
Source: annual report 2025, Danish Business Authority
The financial health of NOBEL BIOCARE DANMARK A/S has shown a concerning decline in profitability over recent years, with increasing losses and deteriorating equity. Gross profit peaked at 4,267,743 DKK in 2021 but has since decreased to 4,044,322 DKK in 2025, while losses escalated from -488,865 DKK in 2022 to -4,810,707 DKK in 2025. The company's equity position has worsened significantly, dropping from 858,111 DKK in 2021 to -10,951,798 DKK in 2025, indicating substantial financial strain. As a manufacturer of medical and dental instruments, the company faces challenges in maintaining a competitive position within the industry, particularly given its declining margins and increasing debt.
AI-generated summary · Generated 15/08/2026
Selskabets formål er udvikling, fabrikation og salg af lægemidler og andre produkter til helse- og sundhedspleje samt kemisk-tekniske artikler, at drive medicinsk-teknisk virksomhed og anden dermed forbunden virksomhed samt at eje og forvalte fast ejendom og løsøre.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 4 mio. | -4.8 mio. | 113.9 mio. | -11 mio. | 3 | |
| 202401/01/2024 – 31/12/2024 | 3.8 mio. | -4.5 mio. | 160 mio. | -6.1 mio. | 3 | |
| 202301/01/2023 – 31/12/2023 | 3.1 mio. | -2 mio. | 154.5 mio. | -1.6 mio. | 4 | |
| 202201/01/2022 – 31/12/2022 | 3.3 mio. | -489 t. | 61 mio. | 369 t. | 3 | |
| 202101/01/2021 – 31/12/2021 | 4.3 mio. | 268 t. | 62.2 mio. | 858 t. | 3 | |
| 202001/01/2020 – 31/12/2020 | 4.8 mio. | -794 t. | 121.2 mio. | -1.4 mio. | 5 | |
| 201901/01/2019 – 31/12/2019 | 4 mio. | -5.5 mio. | 383.7 mio. | -616 t. | 4 | |
| 201801/01/2018 – 31/12/2018 | 3.3 mio. | 420 t. | 24.7 mio. | 4.9 mio. | 3 | |
| 201701/01/2017 – 31/12/2017 | 3.8 mio. | 580 t. | 23.9 mio. | 4.4 mio. | 4 | |
| 201601/01/2016 – 31/12/2016 | 6.3 mio. | 894 t. | 23.8 mio. | 3.9 mio. | 4 | |
| 201501/01/2015 – 31/12/2015 | 5.5 mio. | 578 t. | 6.7 mio. | 3 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 5.2 mio. | 430 t. | 4.9 mio. | 2.4 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 5.3 mio. | 299 t. | 5 mio. | 2 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 6.1 mio. | 409 t. | 8.5 mio. | 4.7 mio. | - |
Compared to 309 companies in Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of NOBEL BIOCARE DANMARK A/S is 28293364.
NOBEL BIOCARE DANMARK A/S is owned by Nobel Biocare AB.
The management of NOBEL BIOCARE DANMARK A/S consists of Jan Jerne.
The board of NOBEL BIOCARE DANMARK A/S consists of Magnus Karl Andreas Pettersson, Harrieth Eva Elisabeth Sundaeus and Jan Jerne, with Magnus Karl Andreas Pettersson as chair.
In 2025, NOBEL BIOCARE DANMARK A/S reported a gross profit of DKK 4,044,322.
NOBEL BIOCARE DANMARK A/S had 3 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2025. Gross profit came to DKK 4,044,322, and the net result was DKK -4,810,707.
As of August 15, 2025, Jan Jerne has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 15, 2025, Jan Jerne is registered as adm. dir. of NOBEL BIOCARE DANMARK A/S.
As of June 30, 2025, Peter Esbjörn Rådqvist has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of June 30, 2025, Peter Esbjörn Rådqvist has stepped down as adm. dir. of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2024. Gross profit came to DKK 3,772,945, and the net result was DKK -4,496,854.
As of May 28, 2025, Peter Esbjörn Rådqvist has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of May 28, 2025, Stefan Fabian Lieb has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of May 28, 2025, Peter Esbjörn Rådqvist is registered as adm. dir. of NOBEL BIOCARE DANMARK A/S.
As of May 28, 2025, Stefan Fabian Lieb has stepped down as adm. dir. of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2023. Gross profit came to DKK 3,122,730, and the net result was DKK -2,013,483.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2022. Gross profit came to DKK 3,338,235, and the net result was DKK -488,865.
As of January 16, 2023, Stefan Fabian Lieb has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of January 16, 2023, Stefan Fabian Lieb is registered as adm. dir. of NOBEL BIOCARE DANMARK A/S.
As of January 15, 2023, Chris James Stahle has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of January 15, 2023, Chris James Stahle has stepped down as adm. dir. of NOBEL BIOCARE DANMARK A/S.
As of September 26, 2022, Chris James Stahle has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of September 26, 2022, Lars Fredrik Strömberg has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of September 26, 2022, Chris James Stahle is registered as adm. dir. of NOBEL BIOCARE DANMARK A/S.
As of September 26, 2022, Lars Fredrik Strömberg has stepped down as director of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2021. Gross profit came to DKK 4,267,743, and the net result was DKK 267,699.
As of August 30, 2022, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of NOBEL BIOCARE DANMARK A/S.
As of August 30, 2022, Lars Fredrik Strömberg has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 30, 2022, Magnus Karl Andreas Pettersson has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 30, 2022, Harrieth Eva Elisabeth Sundaeus has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 30, 2022, Lars Fredrik Strömberg is registered as director of NOBEL BIOCARE DANMARK A/S.
As of August 24, 2022, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of NOBEL BIOCARE DANMARK A/S.
As of August 24, 2022, Harrieth Eva Elisabeth Sundaeus has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 24, 2022, Magnus K. Andreas Pettersson has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 24, 2022, Lars Fredrik Strömberg has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 24, 2022, Lars Fredrik Strömberg has stepped down as director of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2020. Gross profit came to DKK 4,787,016, and the net result was DKK -793,925.
As of December 11, 2020, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of NOBEL BIOCARE DANMARK A/S.
As of December 11, 2020, EY Godkendt Revisionspartnerselskab has stepped down as auditor of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2019. Gross profit came to DKK 3,951,270, and the net result was DKK -5,470,814.
As of June 8, 2020, Lars Fredrik Strömberg has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of June 8, 2020, Hans Braunstein has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of June 8, 2020, Lars Fredrik Strömberg is registered as director of NOBEL BIOCARE DANMARK A/S.
As of June 8, 2020, Hans Braunstein has stepped down as director of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2018. Gross profit came to DKK 3,336,703, and the net result was DKK 419,851.
As of January 9, 2019, Hans Braunstein has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of January 9, 2019, Hans Tobias Nordefjäll has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of January 9, 2019, Jens Henrik Nedoh has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of January 9, 2019, Hans Braunstein is registered as director of NOBEL BIOCARE DANMARK A/S.
As of January 9, 2019, Jens Henrik Nedoh has stepped down as director of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2017. Gross profit came to DKK 3,775,166, and the net result was DKK 580,387.
As of January 15, 2018, Jens Henrik Nedoh is registered as director of NOBEL BIOCARE DANMARK A/S.
As of January 15, 2018, Jan Jerne has stepped down as director of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2016. Gross profit came to DKK 6,274,224, and the net result was DKK 893,845.
As of February 15, 2017, Magnus K. Andreas Pettersson has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of February 15, 2017, Åsa Camilla Elisabeth Johnson has left the board of directors of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2015. Gross profit came to DKK 5,513,299, and the net result was DKK 577,633.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2014. Gross profit came to DKK 5,214,467, and the net result was DKK 429,847.
As of June 18, 2014, Hans Tobias Nordefjäll has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of June 18, 2014, Jens Henrik Nedoh has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of June 18, 2014, Karl Magnus Persson has left the board of directors of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2013. Gross profit came to DKK 5,277,883, and the net result was DKK 298,710.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2012. Gross profit came to DKK 6,081,398, and the net result was DKK 408,697.
As of April 17, 2012, Karl Magnus Persson has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of April 17, 2012, Alexander Johannes Ochsner has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of May 17, 2010, Jan Jerne is registered as director of NOBEL BIOCARE DANMARK A/S.
As of May 17, 2010, Sven Wissing Jensen has stepped down as director of NOBEL BIOCARE DANMARK A/S.
As of March 24, 2009, EY Godkendt Revisionspartnerselskab has been appointed auditor of NOBEL BIOCARE DANMARK A/S.
As of March 24, 2009, CJ Partnership I/S has stepped down as auditor of NOBEL BIOCARE DANMARK A/S.
As of November 3, 2008, Alexander Johannes Ochsner has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of November 3, 2008, Jacques Claude Gutedel has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of May 23, 2008, Jacques Claude Gutedel has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of May 23, 2008, Harrieth Eva Elisabeth Sundaeus has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of May 23, 2008, Thomas Fritz Bögli has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of May 23, 2008, Jan Lars Robert Gottlander has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of October 3, 2007, Sven Wissing Jensen is registered as director of NOBEL BIOCARE DANMARK A/S.
As of October 3, 2007, Kjell Ove Jonsson has stepped down as director of NOBEL BIOCARE DANMARK A/S.
As of February 9, 2007, Åsa Camilla Elisabeth Johnson has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of February 9, 2007, Barbro Michaela Ahlberg has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of February 1, 2006, Kjell Ove Jonsson is registered as director of NOBEL BIOCARE DANMARK A/S.
As of February 1, 2006, Nils Thomas Göran Nortoft has stepped down as director of NOBEL BIOCARE DANMARK A/S.
As of November 24, 2005, Jan Lars Robert Gottlander has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of November 24, 2005, Karl Magnus Persson has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of November 24, 2005, Nils Thomas Göran Nortoft is registered as director of NOBEL BIOCARE DANMARK A/S.
As of November 24, 2005, Karl Magnus Persson has stepped down as director of NOBEL BIOCARE DANMARK A/S.
As of November 24, 2004, CJ Partnership I/S has been appointed auditor of NOBEL BIOCARE DANMARK A/S.
As of November 24, 2004, Barbro Michaela Ahlberg has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of November 24, 2004, Karl Magnus Persson has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of November 24, 2004, Thomas Fritz Bögli has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of November 24, 2004, Karl Magnus Persson is registered as director of NOBEL BIOCARE DANMARK A/S.
As of November 24, 2004, is registered as an owner of NOBEL BIOCARE DANMARK A/S with an ownership share of 100%.
NOBEL BIOCARE DANMARK A/S was founded on November 24, 2004.
Companies in the same industry and area
CVR 45151727
CVR 31749085
CVR 36504579
CVR 12065507
CVR 14178392
